Expert Review of Hematology

Article	Citations
Hemophagocytic lymphohistiocytosis in Egyptian children: diagnosis, treatment challenges, and outcome	54
Are we closer to a standard of care for Richter’s syndrome? Novel treatments on the horizon	54
Immune thrombocytopenia and pregnancy: challenges and opportunities in diagnosis and management	47
Do we need more guidance on thrombophilia testing? Challenges and special considerations	37
A combination of carfilzomib, dexamethasone, and daratumumab for treatment of adult patients with relapsed/refractory multiple myeloma in two dosing regimens: once-weekly and twice-weekly	36
Acalabrutinib: a bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia	27
Frequencies of glycosylphosphatidylinositol (GPI)-deficient cells using high-sensitivity flow cytometry as per the 2018 ICCS/ESCCA consensus guideline in patients with hematologic malignancy, aplastic	27
From bench to bedside: bridging the gaps in best practices for real-world chronic myeloid leukemia care	24
What is the future of digital tools to help manage pain in sickle cell disease patients?	24
Treatment patterns and blood count control in 10,112 patients with polycythemia vera	23
The evolving management algorithm for the patient with newly diagnosed cold agglutinin disease	22
Upfront therapy for diffuse large B-cell lymphoma: looking beyond R-CHOP	22
COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis	21
Hematological parameters and X-ray exposure among medical radiation workers: a systematic review and meta-analysis	21
Treating sickle cell disease in resource-limited sub-Saharan Africa: recent strategies and recommendations in addressing the gaps for the provision of evidence-based management	20
Correlation between hematocrit and the risk of common human cancers: results of a 1999–2020 observational survey and Mendelian randomization analysis	19
Late effects of hemopoietic stem cell transplant for sickle cell disease: monitoring and management	18
Allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: current status and future directions mainly focusing on a Chinese perspective	16
BTK inhibitors: moving the needle on the treatment of chronic lymphocytic leukemia	15
Etranacogene dezaparvovec for the treatment of adult patients with severe and moderately severe hemophilia B	15
Screening and interventional strategies for the late effects and toxicities of hematological malignancy treatments in pediatric survivors	15
Relapse and resistance in acute myeloid leukemia post venetoclax: improving second lines therapy and combinations	15
Extended post-discharge thromboprophylaxis in hospitalized COVID-19 patients	14
The future of siRNA-mediated approaches to treat von Willebrand disease	14
Sickle cell disease and infertility risks: implications for counseling and care of affected girls and women	13

Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera	12
Cost-effectiveness analysis of azacitidine maintenance therapy in patients with acute myeloid leukemia	12
Efanesoctocog alfa for the prevention and treatment of bleeding in patients with hemophilia A	12
Bone marrow aspirate or biopsy for multiple myeloma: when percentages matter!	12
Past, present, and future of orthopedic surgery in hemophilia: looking to a world without bleeding and arthropathy in the near future	12
Impact of atrial fibrillation in onco-hematological patients in Europe: a targeted literature review	12
Efficacy and safety of phosphatidylinositol 3-kinase inhibitors in patients with chronic lymphocytic leukemia: a meta-analysis and systematic review	11
BCL-2 inhibition in acute myeloid leukemia: resistance and combinations	11
Voxelotor for the treatment of sickle cell disease in pediatric patients	11
Patient-centered care in von Willebrand disease: are we there yet?	11
Thrombotic events in children and adolescent patients with SARS-CoV-2 infection: a systematic review with meta-analysis on incidence and management	10
Is next-generation sequencing the future of measurable residual disease assays for Philadelphia chromosome-positive acute lymphoblastic leukemia?	10
New directions to develop therapies for people with hemophilia	10
Managing blood supplies during natural disasters, humanitarian emergencies, and pandemics: lessons learned from COVID-19	10
Radiation therapy prior to CAR T-cell therapy in lymphoma: impact on patient outcomes	10
Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients	10
Development and internal validation of a prediction model for patients with hematologic diseases of fall risk: a cohort study	10
Optimizing long-term joint health in the treatment of hemophilia	9
The National Hemophilia Foundation’s State of the Science Research Summit: the foundation of a national research blueprint for inherited bleeding disorders	9
A real-world evidence analysis of the impact of switching from factor VIII to emicizumab prophylaxis in patients with hemophilia A without inhibitors	9
Dose optimisation of ponatinib in chronic phase chronic myeloid leukemia	9
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding	9
Rivaroxaban plus aspirin after lower–extremity revascularization	9
What is the importance of monitoring iron levels in different organs over time with magnetic resonance imaging in transfusion-dependent thalassemia patients?	9
Emicizumab and unmet needs of patients with hemophilia a who are managed with replacement therapies	9
Molecular targets for the treatment of AML in the forthcoming 5th World Health Organization Classification of Haematolymphoid Tumours	9
Real-world treatment patterns and outcomes in people with von Willebrand disease treated prophylactically with recombinant von Willebrand factor in the United States	9
Is the occurrence of deep vein thrombosis related to the fracture site? A two-sample Mendelian randomization study	9
Bad players in AL amyloidosis in the current era of treatment	8
Hematology in the post-COVID era: spotlight on vaccine-induced immune thrombotic thrombocytopenia and a conceptual framework (the 4P’s) for anti-PF4 diseases	8
Role of volumetric analyses on [18F]FDG PET/CT in pediatric Hodgkin lymphoma	8
Lived experience experts: a name created by us for us	8
The association between hemoglobin level, anemia, and hypertension among adolescents in Sudan: a multicenter cross-sectional study	8
Oral decitabine in acute myeloid leukemia: assessing efficacy, safety, and future implications for older patients	8
A review of the isocitrate dehydrogenase inhibitors in management of adult patients with AML and MDS	8
Pegcetacoplan: the first and only C3-targeted therapy for the treatment of adults with paroxysmal nocturnal hemoglobinuria	8
Long-term follow-up of patients with hairy cell leukemia in the south of Iran	8
Indicators of an increased risk of therapy-related myeloid neoplasms in lymphoma patients: how can we best evaluate severe impairment of bone marrow function?	7
Pomalidomide combined with dexamethasone for the treatment of relapsed/refractory multiple myeloma: a systematic review and meta-analysis	7
Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpura	7
Monoclonal antibodies used for the management of hemataological disorders	7
Trends of chronic lymphocytic leukemia incidence and mortality in the United States: a population-based study over the last four decades	7
Problems faced by people with hemophilia aged 18–35 years in social life: a qualitative study	7
Bridging the gap: how do we enroll more racial-ethnic minority patients in hematological drug trials?	7
An update on novel therapies for treating patients with arterial thrombosis	7
Sickle cell disease in gulf cooperation council countries: a systematic review	7
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders	7
Mesenchymal stromal cells for the prophylaxis of graft-versus-host disease after hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials	7
Hematological disorders in children with Down syndrome	7
Genetic variant of endothelial protein C receptor genes and its serum level in B thalassemic children	7

Revisiting the prognostic role of FLT3 mutations in acute myelogenous leukemia	7
The impact of oral health promotion on the quality of life of children with bleeding disorders: fighting misconceptions	7
Advances in our understanding of genetic markers and targeted therapies for pediatric LCH	7
Advancements in targeting CD30 for lymphoma therapy: a historical perspective and future directions	7
NSAIDS/COXIBS for the treatment of musculoskeletal pain secondary to hemophilic arthropathy	6
Incidence, prevention and management of severe infections in patients undergoing therapy for chronic lymphocytic leukemia	6
Challenges facing minimal residual disease testing for acute myeloid leukemia and promising strategies to overcome them	6
Revisiting the role of measurable residual disease in FLT3 mutated acute myelogenous leukemia	6
Development of CD30 CAR-T cells in refractory or relapsed Hodgkin’s lymphoma	6
Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategies	6
Circ_0035381 contributes to the progression of acute myeloid leukemia via regulating miR-186-5p/CDCA3 pathway	6
An observational study of disease management in adult patients with polycythemia vera: results from a large U.S. claims database	6
Efficacy and safety evaluation of eptacog beta (coagulation factor VIIa [recombinant]-jncw) for the treatment of hemophilia A and B with inhibitors	6
Understanding the interplay between chronic lymphocytic leukemia and type 2 diabetes	6
Exploring the genetic relationship between deep vein thrombosis and plasma protein: a new research idea	6
Targeting von Willebrand disease: the current status and future directions of management therapies	6
Identifying prognostic gene panels in acute myeloid leukemia	6
Exploring health disparities in diagnosing multiple myeloma	6
Navigating the gap between guidelines and practical challenges in selecting first-line therapy for chronic lymphocytic leukemia	6
An evaluation of mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency	6
Secondary primary malignancies after treatment with chemo-immunotherapy in treatment-naïve patients with CLL: a systematic literature review	6
A systematic literature review of the epidemiology, quality of life, and economic burden, including disease pathways and treatment patterns of relapsed/refractory classical Hodgkin lymphoma	6
Challenges in the diagnosis of thrombotic thrombocytopenic purpura	6
Novel BCR-ABL1 tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia	6
Curative effect of motherwort combined with ethinylestradiol-cyproterone acetate on dysfunctional uterine bleeding	6
Kompetitive allele specific PCR (KASP) based genotyping of sickle gene in the selected sub-ethnic tribal population of Gujarat and Madhya Pradesh	6
Revolutionizing hypertension treatment: aprocitentan’s dual action against resistant hypertension	5
How clinicians and persons with hemophilia may approach shared decision-making	5
Immunotherapy for myelodysplastic syndrome and acute myeloid leukemia: where do we stand?	5
Effectiveness of myofascial therapy (MFT) along with traditional physiotherapy and intermittent prophylaxis on short-term improvement of joint health in hemophilic arthropathy: a randomized control tr	5
CircPTK2 promotes cell viability, cell cycle process, and glycolysis and inhibits cell apoptosis in acute myeloid leukemia by regulating miR-582-3p/ALG3 axis	5
Practical tips for managing FLT3 mutated acute myeloid leukemia with midostaurin	5
Modifiable lifestyle risk factors and survival after diagnosis with multiple myeloma	5
HIV-1 infection in sickle cell disease and sickle cell trait: role of iron and innate response	5
The role of staging in multiple myeloma	5
Procalcitonin as a diagnostic marker for infection in sickle cell disease	5
Five decades of successive establishment of hemophilia care in Thailand	5
Pacritinib for the treatment of patients with myelofibrosis and thrombocytopenia	5
Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: a systematic literature review	5
Vasculopathy among children and adolescents with sickle cell disease: the crosstalk with annexin A1, vitamin D, and myocardial iron overload	5
Proactive measures to reduce maternal mortality and post-partum hemorrhage in sub-Saharan Africa: the hematology perspective	5
A new decade awaits sticky platelet syndrome: where are we now, how do we manage and what are the complications?	5
Novel approaches for preventing COVID-19 infection in immunocompromised patients with hematologic malignancies	4
Gene polymorphisms predicting response to hydroxyurea treatment in Bahraini patients with sickle cell disease	4
Magnitude of anemia and associated factors among adult patients at Baso Liben District: a cross-sectional study	4
The past, the present and the future of immune checkpoints inhibitors in multiple myeloma	4
Targeting CD123 in BPDCN: an emerging field	4
Long non-coding RNA LOC644135 is a potential prognostic indicator in cytogenetically normal acute myeloid leukemia	4
Exploring the rationale for red cell transfusion in myelodysplastic syndrome patients: emerging data and future insights	4
Inhibitor eradication and treatment for acquired hemophilia A	4
An evaluation of fedratinib for adult patients with newly diagnosed and previously treated myelofibrosis	4
An overview of novel therapies in advanced clinical testing for acute myeloid leukemia	4
Copper deficiency, a rare but correctable cause of pancytopenia: a review of literature	4
The prognostic power of MMP-9 in diffuse large B-cell lymphoma	4
Cognitive impairment in hematology patients planned for chimeric antigen receptor T-cell therapy	4
t(4;14), and revised myeloma comorbidity index as good predictors of survival for multiple myeloma	4
Challenges and considerations for antifungal prophylaxis in children with acute myeloid leukemia	4
An evaluation of deferiprone as twice-a-day tablets or in combination therapy for the treatment of transfusional iron overload in thalassemia syndromes	4
The benefits of early intervention using lenalidomide for high-risk smoldering multiple myeloma: emerging data and its promising clinical impact	4
Evaluating ravulizumab for the treatment of children and adolescents with paroxysmal nocturnal hemoglobinuria	4
Managing patients with myelofibrosis and thrombocytopenia	4
A deep dive into future therapies for microcytic anemias and clinical considerations	4
Nutritional status of patients with lymphoproliferative neoplasms before and after the first-line treatment	4
Advances in viral oncolytics for treatment of multiple myeloma – a focused review	4
Real-world treatment patterns and outcomes of triple-class treated patients with multiple myeloma in the United States	4
Anti-tissue factor pathway inhibitors for hemophilia: are these treatments the answer to overcoming current treatment limitations?	4
Effect of hydroxyurea on erythrocyte apoptosis in hemoglobinopathy patients	4
CD8+CD25+ Tregs as a predictor of glucocorticoid sensitivity in patients with immune thrombocytopenia	4
Letter to the Editor on “Hematopoietic cell transplants in resource-poor countries: challenges and opportunities”	4
Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review	4
Comparison of blinatumomab and CAR T-cell therapy in relapsed/refractory acute lymphoblastic leukemia: a systematic review and meta-analysis	4
Relationship between the ABO blood group and Rhesus factors with COVID-19 susceptibility	4
To enhance the detection of aplastic anemia in primary care settings: a population-based study in Italy	3
Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis	3
Reduced-intensity conditioning for allogeneic transplantation in classical Hodgkin lymphoma	3
Foreword: a special focus on bleeding disorders	3
The National Hemophilia Foundation State of the Science Research Summit initiative: executive summary	3
Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies	3
Clinical study on the prevention of deep vein thrombosis in patients with external fixation of lower limb fractures using an automatic ankle pump movement ceramic moxibustion rehabilitation device	3
Complex interaction of δ-globin variant HbA 2 -Famagusta combined with β-globin variant Hb Monroe in cis with the HBB:c.-92C>G muta	3

Pregnancy and sickle cell disease: an overview of complications and suggested perinatal care	3
New developments in the diagnosis and characterization of Waldenström’s macroglobulinemia	3
Soliciting international perspectives on an American national research agenda for inherited bleeding disorders	3
Emerging small molecular inhibitors as targeted therapies for high-risk acute myeloid leukemias	3
Reduction of ristocetin-induced platelet aggregation (RIPA) during storage despite plasma renewal: evidence for hemostatic importance of GPIbα shedding	3
Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection	3
The promise of novel treatments for severe chronic neutropenia	3
Identifying people with acute lymphoblastic leukemia who are most suitable for treatment with inotuzumab ozogamicin: a plain language summary	3
The potential of triplet combination therapies for patients with FLT3-ITD -mutated acute myeloid leukemia	3
G-CSF primary prophylaxis use and outcomes in patients receiving chemotherapy at intermediate risk for febrile neutropenia: a scoping review	3
The role of intraarticular injections of hyaluronic acid in joint pain relief in hemophilic arthropathy	3
Efficacy and safety of thrombopoietin receptor agonists in the treatment of thrombocytopenia after hematopoietic stem cell transplantation: a meta-analysis and systematic review	3
Proximal complement inhibitors in paroxysmal nocturnal hemoglobinuria: an abundance of options in a rare disease	3
Positron emission tomography/magnetic resonance imaging (PET/MRI) vs. gastroscopy: Can it improve detection of extranodal marginal zone lymphomas of the stomach following H. pylori treatment?	3
Evaluating zanubrutinib for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma	3
Is intensive chemotherapy and allogeneic stem cell transplantation mandatory for curing Philadelphia chromosome-positive acute lymphoblastic leukemia in young patients in the era of multitarget agents	3
Thrombo-vera: a new thrombosis risk model for polycythemia vera using modern variable selection methods	3
Next generation anticoagulants: a spotlight on the potential role of activated factors XII and XI	3
Correction	3
Post-transplant sorafenib effectively prevents relapse in FLT3-mutated acute myeloid leukemia	3
Update on iron supplementation in patients with cancer-related anemia	3
Quality of life considerations and management in patients with myelodysplastic syndrome	2
Emicizumab: a novel drug in hemophilia A prophylaxis – a narrative review	2
Subanesthetic ketamine: the way forward for pain management in sickle cell disease patients?	2
Factor first! Emergency department management of persons with hemophilia: a single-center study	2
Immune thrombocytopenia: a review on the pathogenetic role of immune cells	2
How will genomic testing impact a clinician’s choice for managing chronic myeloid leukemia?	2
Ankle arthrodesis and total ankle replacement in patients with congenital bleeding disorders suffering from severe ankle arthropathy	2
Cartilage degeneration in hemophilic arthropathy: to focus on prevention or regeneration?	2
Preformed anti-HLA DQA1/DQB1 DSA possibly responsible for graft failure in haploidentical stem cell transplantation	2
Could targeted gene insertion of factor 9 be a potential durable treatment for Hemophilia B?	2
Predictors of progression to chronicity in newly diagnosed primary immune thrombocytopenia: a retrospective multicenter French study	2
Cyclophosphamide and horse anti-thymocyte globulin versus fludarabine, reduced cyclophosphamide and rabbit anti-thymocyte globulin conditioning regimen for allogeneic hematopoietic stem cell transplan	2
Global prophylaxis trends in hemophilia: a macroeconomic analysis and its association with world development indicators	2
Olutasidenib: a novel mutant IDH1 inhibitor for the treatment of relapsed or refractory acute myeloid leukemia	2
Current therapies for chronic lymphocytic leukemia: risk and prophylaxis strategies for secondary/opportunistic infections	2
Looking to the future of gene therapy for hemophilia A and B	2
Anemia and iron overload as prognostic markers of outcomes in β-thalassemia	2
DNA damage repair in megakaryopoiesis: molecular and clinical aspects	2
Gastrointestinal bleeding in von Willebrand patients: special diagnostic and management considerations	2
Dysregulated MAPK signaling pathway in acute myeloid leukemia with RUNX1 mutations	2
Enoxaparin adherence for venous thromboembolism prophylaxis in hospitalized patients with sickle cell disease	2
Overexpression of SCN5A overcomes ABC transporter-mediated multidrug resistance in acute myeloid leukemia through promoting apoptosis	2
Redefining efficacy and safety endpoints for chronic lymphocytic leukemia in the era of targeted therapy	2
The efficiency of autologous stem cell transplantation as the first-line treatment for nodal peripheral T-cell lymphoma: results of a systematic review and meta-analysis	2
Synovitis in hemophilia: preventing, detecting, and treating joint bleeds	2
Improving care for systemic light-chain amyloidosis patients: is a multidisciplinary approach best?	2
Reduced CXCR4 expression in associated with extramedullary and predicts poor survival in newly diagnosed multiple myeloma	2
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia	2
Modulation of the endocannabinoid system in chronic conditions: a potential therapeutic intervention yet to be explored in sickle cell disease	2
An evaluation of von Willebrand factor (recombinant) therapy for adult patients living with severe type 3 von Willebrand disease	2
A systematic review of histological characteristics in arterial and venous thrombi	2
Is 50 mg/day the new standard dose of dasatinib in newly diagnosed patients with chronic myeloid leukemia in chronic phase?	2
Platelet indices in preeclampsia: comparative analysis with normotensive pregnant women	2
MiR-106b-5p, MiR-200c-3p, and MiR-146a-5p expression as putative biomarkers for disease state in primary immune thrombocytopenia	2
Addressing thrombosis concerns in immune thrombocytopenia: the role of fostamatinib in immune thrombocytopenia management	2
Emerging roles of microRNAs in acute lymphoblastic leukemia and their clinical prospects	2
The diagnosis, natural history, and management of von Willebrand disease in women in the age of guidelines	2
Identification and management of fetal anemia due to hemolytic disease	2
Effect of days of age at first blood transfusion on intraventricular hemorrhage in very low and extremely low birth weight infants	2
Polycythemia vera: aspects of its current diagnosis and initial treatment	2
Quality of life considerations in myelodysplastic syndrome: not only fatigue	2
A systematic review of the predicted outcomes related to hematopoietic stem cell transplantation: focus on applied machine learning methods’ performance	1
Nodular lymphocyte-predominant Hodgkin lymphoma: current management strategies and evolving approaches to individualize treatment	1
An expert review of voxelotor for the treatment of hemolytic anemia in patients with sickle cell disease: ‘bridging the gap between laboratory data and patient related outcomes’	1
Management of acute chest syndrome in patients with sickle cell disease: a systematic review of randomized clinical trials	1
Risk of vaso-occlusive episodes in patients with sickle cell disease exposed to systemic corticosteroids: a comprehensive review	1
In the era of primary prophylaxis in hemophilia, what types of orthopedic surgical interventions have been published in the 2020–2023 period and in which countries?	1
Clinical trials, challenges, and changes in TCR-based therapeutics for hematologic malignancies	1
Frontline combination of dasatinib and low-intensity chemotherapy in adults with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia	1
A narrative review of consolidation strategies for young and fit patients with newly-diagnosed primary central nervous system lymphoma	1
Efficacy of azacitidine in preventing relapse after hematopoietic stem cell transplantation for advanced myeloid malignancies: a systematic review and meta-analysis	1
Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopenia	1
Trends in non-Hodgkin lymphoma mortality: global, regional, and national insights from 1990 to 2021	1
Strategies to improve pharmacogenomic-guided treatment options for patients with β-hemoglobinopathies	1
CRISPR-based gene therapy for the induction of fetal hemoglobin in sickle cell disease	1
Efficacy and safety of caplacizumab in the treatment of thrombotic thrombocytopenic purpura: a systematic review and meta-analysis	1
Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A: interim results from a phase 3, prospective, multicenter, open-label study	1
Total elbow arthroplasty in hemophilia: a high-risk surgical procedure	1
Exercise and anemia in cancer patients: could it make the difference?	1
Utilizing the prognostic impact of minimal residual disease in treatment decisions for pediatric acute lymphoblastic leukemia	1
Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians	1
Chemotherapy-free approaches to newly-diagnosed acute promyelocytic leukaemia: is oral-arsenic trioxide/all-trans retinoic acid/ascorbic acid the answer?	1
Hemophilic arthropathy: a teaching approach devoted to hemophilia treaters in under-development countries	1
What are the therapeutic options for previously treated myelofibrosis?	1
Complement-directed therapy for cold agglutinin disease: sutimlimab	1
BCMA-targeted therapies for multiple myeloma: strategies to maximize efficacy and minimize adverse events	1
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders	1
Graft-versus-host disease after an outpatient peripheral blood hematopoietic cell transplant using reduced-intensity conditioning: a single-center LATAM experience	1
Evaluation of the effect of voxelotor and darbepoetin alfa on hemoglobin levels in patients with sickle cell disease	1
Assessing eligibility for treatment in acute myeloid leukemia in 2023	1
Real-world study of rurioctocog alfa pegol and emicizumab in US clinical practice among patients with hemophilia A	1
Mucosal toxicity in hematological malignancies: prevention, management, and novel therapeutic insights	1
Does Down syndrome affect the prognosis of acute lymphoblastic leukemia? A systematic review and meta-analysis	1
Current state-of-the-art of immunotherapy in follicular lymphoma	1